Increased CYP4B1 mRNA Is Associated with the Inhibition of Dextran Sulfate Sodium-Induced Colitis by Caffeic Acid in Mice
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ye, Zhong | - |
dc.contributor.author | Liu, Zhiping | - |
dc.contributor.author | Henderson, Abigail | - |
dc.contributor.author | Lee, Kwangwon | - |
dc.contributor.author | Hostetter, Jesse | - |
dc.contributor.author | Wannemuehler, Michael | - |
dc.contributor.author | Hendrich, Suzanne | - |
dc.date.accessioned | 2021-09-08T16:17:44Z | - |
dc.date.available | 2021-09-08T16:17:44Z | - |
dc.date.created | 2021-06-10 | - |
dc.date.issued | 2009-06 | - |
dc.identifier.issn | 1535-3702 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/119855 | - |
dc.description.abstract | Susceptibility to inflammatory bowel diseases depends upon interactions between the genetics of the individual and induction of chronic mucosal inflammation. We hypothesized that administration of dietary phenolics, caffeic acid and rutin, would suppress upregulation of inflammatory markers and intestinal damage in a mouse model of colitis. Colitis was induced in C3H/HeOuJ mice (8 weeks old, 6 male/6 female per treatment) with 1.25% dextran sulfate sodium (DSS) for 6 d in their drinking water. Rutin (1.0 mmol (524 mg)/kg in diet), caffeic acid (1.0 mmol (179 mg)/kg in diet), and hypoxoside extract (15 mg/d, an anticolitic phenolic control) were fed to the mice for 7 d before and during DSS treatment, as well as without DSS treatment. Body weight loss was prevented by rutin and caffeic acid during DSS treatment. Colon lengths in mice fed caffeic acid and hypoxoside during DSS treatment were similar to DSS-negative control. Food intake was improved and myeloperoxidase (MPO) was decreased with each phenolic treatment in DSS-treated mice compared with DSS treatment alone. Colonic mRNA expression of IL-17 and NOS were inhibited when IL-4 was increased by each phenolic treatment combined with DSS, whereas CYP4B1 mRNA was increased only by caffeic acid in DSS-treated mice, compared with DSS treatment alone. Colonic and cecal histopathology scores of DSS-treated mice were significantly more severe (P < 0.01) than in mice fed caffeic acid before and during DSS treatment, based on mucosal height, necrosis, edema, erosion, and inflammatory cell infiltration. Although both rutin and caffeic acid suppressed the expression of selected inflammatory markers, only caffeic acid protected against DSS-induced colitis, in association with normalization of CYP4B1 expression. The inhibition of DSS-induced colitic pathology by caffeic acid was mediated by mechanisms in addition to anti-inflammatory effects that deserve further study. Exp Biol Med 234:605-616, 2009 | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | SAGE PUBLICATIONS LTD | - |
dc.subject | INFLAMMATORY-BOWEL-DISEASE | - |
dc.subject | NF-KAPPA-B | - |
dc.subject | ENHANCED MURINE MODEL | - |
dc.subject | PHENETHYL ESTER CAPE | - |
dc.subject | GENE-EXPRESSION | - |
dc.subject | NITRIC-OXIDE | - |
dc.subject | PHARMACOGENE THERAPY | - |
dc.subject | CYTOCHROME-P450 4B1 | - |
dc.subject | HELICOBACTER-BILIS | - |
dc.subject | IMMUNE REACTIVITY | - |
dc.title | Increased CYP4B1 mRNA Is Associated with the Inhibition of Dextran Sulfate Sodium-Induced Colitis by Caffeic Acid in Mice | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Kwangwon | - |
dc.identifier.doi | 10.3181/0901-RM-1 | - |
dc.identifier.scopusid | 2-s2.0-66449112764 | - |
dc.identifier.wosid | 000266770400001 | - |
dc.identifier.bibliographicCitation | EXPERIMENTAL BIOLOGY AND MEDICINE, v.234, no.6, pp.605 - 616 | - |
dc.relation.isPartOf | EXPERIMENTAL BIOLOGY AND MEDICINE | - |
dc.citation.title | EXPERIMENTAL BIOLOGY AND MEDICINE | - |
dc.citation.volume | 234 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 605 | - |
dc.citation.endPage | 616 | - |
dc.type.rims | ART | - |
dc.type.docType | Article; Proceedings Paper | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Research & Experimental Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, Research & Experimental | - |
dc.subject.keywordPlus | INFLAMMATORY-BOWEL-DISEASE | - |
dc.subject.keywordPlus | NF-KAPPA-B | - |
dc.subject.keywordPlus | ENHANCED MURINE MODEL | - |
dc.subject.keywordPlus | PHENETHYL ESTER CAPE | - |
dc.subject.keywordPlus | GENE-EXPRESSION | - |
dc.subject.keywordPlus | NITRIC-OXIDE | - |
dc.subject.keywordPlus | PHARMACOGENE THERAPY | - |
dc.subject.keywordPlus | CYTOCHROME-P450 4B1 | - |
dc.subject.keywordPlus | HELICOBACTER-BILIS | - |
dc.subject.keywordPlus | IMMUNE REACTIVITY | - |
dc.subject.keywordAuthor | caffeic acid | - |
dc.subject.keywordAuthor | rutin | - |
dc.subject.keywordAuthor | colitis | - |
dc.subject.keywordAuthor | CYP4B1 | - |
dc.subject.keywordAuthor | inflammation | - |
dc.subject.keywordAuthor | mouse | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.